Skip to main content

Foresite Capital Management V, LLC

13F filer · CIK 0001792206
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$362MU.S. long equity reported on 13F
Positions91 new · 1 closed
Net flow last quarter+$34.1MBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20269 positions
ALMSAlumis Inc.$166M45.81%Not reportedNot reportedQ2 2024
CGONCG Oncology, Inc.$76.7M21.17%1.22%+7.5%Q1 2024
IRONDisc Medicine, Inc.$27.4M7.55%0.98%Not reportedQ4 2022
HIMSHims & Hers Health, Inc.$25.6M7.07%Not reportedNot reportedQ1 2021
PHVSPharvaris N.V.$23M6.34%1.02%+242.1%Q1 2021
EIKNEikon Therapeutics, Inc.$17.2M4.75%2.44%Not reportedQ1 2026
ODTXOdyssey Therapeutics, Inc.$13.3M3.68%1.49%NewQ2 2026
LYELLyell Immunopharma, Inc.$6.69M1.85%2.04%-0.2%Q4 2024
NRIXNurix Therapeutics, Inc.$6.43M1.77%0.26%Not reportedQ4 2020
Q1 2026Reported May 15, 20269 positions
ALMSAlumis Inc.$130M47.94%Not reported+2.0%Q2 2024
CGONCG Oncology, Inc.$68M25.08%1.14%Not reportedQ1 2024
IRONDisc Medicine, Inc.$23.9M8.83%0.98%+25.1%Q4 2022
HIMSHims & Hers Health, Inc.$15.3M5.65%Not reported+170.2%Q1 2021
EIKNEikon Therapeutics, Inc.$14M5.15%2.44%NewQ1 2026
LYELLyell Immunopharma, Inc.$9.57M3.53%2.05%Not reportedQ4 2024
PHVSPharvaris N.V.$5.48M2.02%0.30%Not reportedQ1 2021
NRIXNurix Therapeutics, Inc.$4.11M1.52%0.26%Not reportedQ4 2020
MAZEMaze Therapeutics, Inc.$773K0.29%0.05%-70.0%Q1 2025
Q4 2025Reported Feb 17, 20267 positions
ALMSAlumis Inc.$56.4M34.31%Not reportedNot reportedQ2 2024
CGONCG Oncology, Inc.$41.7M25.36%1.24%Not reportedQ1 2024
IRONDisc Medicine, Inc.$23.7M14.45%0.79%Not reportedQ4 2022
NTRANatera, Inc.$15.4M9.39%0.05%NewQ4 2025
LYELLyell Immunopharma, Inc.$14.7M8.93%2.24%Not reportedQ4 2024
HIMSHims & Hers Health, Inc.$8.87M5.39%Not reportedNot reportedQ1 2021
MAZEMaze Therapeutics, Inc.$3.58M2.17%0.17%Not reportedQ1 2025
Q3 2025Reported Nov 14, 20256 positions
CGONCG Oncology, Inc.$40.4M37.19%1.28%Not reportedQ1 2024
ALMSAlumis Inc.$23.1M21.21%Not reportedNot reportedQ2 2024
IRONDisc Medicine, Inc.$19.8M18.17%0.85%Not reportedQ4 2022
HIMSHims & Hers Health, Inc.$15.5M14.25%Not reportedNot reportedQ1 2021
LYELLyell Immunopharma, Inc.$7.75M7.12%2.47%+17.3%Q4 2024
MAZEMaze Therapeutics, Inc.$2.24M2.06%0.18%-75.0%Q1 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.